🇺🇸 FDA
Patent

US 8252807

Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products

granted A61KA61K31/352A61K31/7068

Quick answer

US patent 8252807 (Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products) held by The Board of Regents of the University of Texas System expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/352, A61K31/7068